Community education and navigation to improve breast cancer screening uptake in Malaysia

Not Applicable

Completed

• Conditions: Clinical Breast Examination (CBE) screening for breast cancer early detection; Cancer

• Registration Number: ISRCTN15196866
• Lead Sponsor: Queen's University Belfast

Brief Summary

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37796803/ (added 08/11/2023)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-03-31
• Study Start: 2022-08-10
• Last Update Posted: 20 November 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 483

Inclusion Criteria

1. Residents from Sungai Segamat and Jabi (Malaysia) who were recorded in the South East Asia Community Observatory (SEACO) database, completed the 2018 SEACO health survey and have previously given consent to be contacted about participating in other research studies.
2. Women aged 40 - 74 years
3. Registered a phone number with SEACO. Only women who were able to provide a mobile phone number when contacted were able to participate in the study.

Exclusion Criteria

1. Breast cancer patients and survivors.
2. Women who reported to the researchers at the time of the interview that they are experiencing breast cancer symptoms were excluded from the research and encouraged to seek help from their local doctor as soon as possible.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical breast examination (CBE) screening uptake measured using records from the LPPKN clinic at follow-up as well as self-reported data at baseline and follow-up.

Secondary Outcome Measures

Name	Time	Method
<br> 1. Breast cancer symptom recognition measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up.<br> 2. Intention to attend a CBE measured using the question ‘I intend to have a Clinical Breast Examination to check for breast cancer in the near future’ and a 5-point Likert scale for participants to rate their response at baseline and follow-up.<br> 3. Beliefs and barriers regarding breast cancer and breast cancer screening measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up.<br> 4. Practice of breast self-examination measured using the Breast Cancer Awareness Measure for Malaysia (B-CAM-M) at baseline and follow-up.<br> 5. Mammogram screening attendance (for CBE-positive women) measured using LPPKN clinic records at follow-up.<br>